This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.

Novel technologies and approaches for optimizing antibody discovery - WHITEPAPER

ArticleImage

WHITEPAPER: Novel technologies and approaches for optimizing antibody discovery

Successful antibody discovery has been dependent on the proper identification of a target and the mechanisms of action associated to the development of a specific disease. But, this conventional wisdom of the antibody development roadmap is being challenged, by how long it takes from target research to the initiation of a clinical program. As the search for validated targets becomes more challenging, unconventional strategies, such as phenotypic screening, are becoming more significant.

This whitepaper examines the latest innovations addressing the current practical challenges in antibody discovery, including:

  • Phenotypic screening and 'function-first' approaches

  • Next generation sequencing and its challenges

  • Bioinformatics tools for antibody optimization

  • Machine learning techniques for target deconvolution


To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.

This piece represents the views of the author and not necessarily the views of Informa Connect Life Sciences or the Antibody Engineering & Therapeutics conference series.

Log in or create an Informa Connect account to access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.